High disease activity is associated with higher blood pressure in recent onset rheumatoid arthritis patients, post-hoc analyses of IMPROVED study

Autor: SA Bergstra, CF Allaart, H Maassen, M Gegenava

Publikováno v: European Journal of Preventive Cardiology. 28

Funding Acknowledgements Type of funding sources: None. Background Rheumatoid arthritis (RA) is a chronic autoimmune disease with a high prevalence of cardiovascular morbidity and mortality. Purpose: purpose of our project was to investigate the asso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a3f337c9520fcfeac740b61d5c5aa91
https://doi.org/10.1093/eurjpc/zwab061.388

The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects

Autor: PH Reitsma, SR Poort, CF Allaart, E Briet, RM Bertina

Publikováno v: Blood. 78(4)

Heterozygosity for protein C deficiency is associated with thromboembolic episodes, but clinical symptoms are nonrandomly distributed among protein C deficient families. This finding has led to the provisional definition of clinically dominant and cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3114bd0d08417b67d5f49a332c3fafc7
https://pubmed.ncbi.nlm.nih.gov/1868249

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study.

Autor: Aranow C; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA caranow@northwell.edu., Allaart CF; Leids Universitair Medisch Centrum, Leiden, The Netherlands., Amoura Z; Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France., Bruce IN; Kellgren Centre for Rheumatology, Manchester University Hospitals NHS Trust, Manchester, UK.; Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Cagnoli PC; University of Michigan Medical Center, Ann Arbor, Michigan, USA., Chatham WW; University of Alabama at Birmingham, Birmingham, Alabama, USA., Clark KL; Clinical Science, GSK, Stevenage, UK., Furie R; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA., Groark J; Clinical Development, GSK, Collegeville, Pennsylvania, USA., Urowitz MB; Toronto Western Hospital, University of Toronto, Lupus Clinic, Toronto, Ontario, Canada., van Vollenhoven R; Amsterdam University Medical Center, Amsterdam Rheumatology Center, Amsterdam, The Netherlands., Daniels M; Global Medical Affairs, GSK, Brentford, UK., Fox NL; Clinical Development, GSK, Collegeville, Pennsylvania, USA., Gregan YI; Clinical Science Immunology, GSK, Collegeville, Pennsylvania, USA., Henderson RB; Clinical Biomarker Group, GSK, Stevenage, UK., van Maurik A; Clinical Biomarker Group, GSK, Stevenage, UK., Ocran-Appiah JC; Clinical Science, Respiratory and Immunology Clinical Research and Early Programs, GSK, Philadelphia, Pennsylvania, USA., Oldham M; Biostatistics, GSK, Stevenage, UK., Roth DA; Research and Development, GSK, Collegeville, Pennsylvania, USA., Shanahan D; Development Biostatistics, GSK, GSK House, Brentford, UK., Tak PP; Research and Development, GSK, Stevenage, UK., Teng YO; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 21; Vol. 83 (11), pp. 1502-1512. Date of Electronic Publication: 2024 Oct 21.

Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.

Autor: van Dijk BT; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands. B.T.van_Dijk@lumc.nl.; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands. B.T.van_Dijk@lumc.nl., Bergstra SA; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands., van den Berg JM; Department of Paediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital / Amsterdam University Medical Centres, Amsterdam, the Netherlands., Schonenberg-Meinema D; Department of Paediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital / Amsterdam University Medical Centres, Amsterdam, the Netherlands., van Suijlekom-Smit LWA; Department of Paediatric Rheumatology, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, the Netherlands., van Rossum MAJ; Department of Paediatrics, Emma Children's Hospital / Amsterdam University Medical Centres, Amsterdam, the Netherlands.; Department of Paediatric Rheumatology, Amsterdam Rheumatology and Immunology Centre (Reade), Amsterdam, the Netherlands., Koopman-Keemink Y; Department of Paediatrics, Juliana Children's Hospital / HagaZiekenhuis, the Hague, the Netherlands., Ten Cate R; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands., Allaart CF; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands., Brinkman DMC; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands., Hissink Muller PCE; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands.

Publikováno v: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 May 10; Vol. 22 (1), pp. 53. Date of Electronic Publication: 2024 May 10.

Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies.

Autor: Heckert SL; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Maassen JM; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Nevins I; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Baudoin P; Rheumatology, Rheumatology, Reumazorg Zuid West Nederland, Roosendaal, The Netherlands., Steup-Beekman GM; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.; Rheumatology, Haaglanden Medical Center, The Hague, The Netherlands., Huizinga TWJ; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Bergstra SA; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Allaart CF; Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Apr 01. Date of Electronic Publication: 2024 Apr 01.